Related Experiment Video
Updated: Sep 27, 2025
Defined and Scalable Generation of Hepatocyte-like Cells from Human Pluripotent Stem Cells
Published on: March 2, 2017
Efficiently generate functional hepatic cells from human pluripotent stem cells by complete small-molecule strategy
Tingcai Pan1,2, Ning Wang2, Jiaye Zhang2
1General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou , Guangdong, China.
Small molecules provide a cost-effective method for generating functional human hepatic cells from pluripotent stem cells. This approach bypasses expensive growth factors, enabling scalable production for therapeutic and research applications.
Area of Science:
- Stem Cell Biology
- Hepatology
- Chemical Biology
Background:
- Generating hepatic cells from human pluripotent stem cells (hPSCs) traditionally requires expensive growth factors, hindering large-scale production.
- Small molecules present a more economical and stable alternative for hepatic cell generation.
Purpose of the Study:
- To identify optimal small-molecule combinations for efficient hepatic cell differentiation, expansion, and maturation from hPSCs.
- To develop a cost-effective and scalable protocol for producing functional human hepatic cells.
Main Methods:
- Utilized small-molecule cocktails to induce definitive endoderm (DE) formation, promoting endogenous TGF-β/Nodal signaling.
- Employed a combination of Vitamin C, Dihexa, and Forskolin (VDF) to replace growth factors for hepatic specification.
- Established stepwise chemical formulas for the expansion and maturation of hepatoblasts (HBs) into functional hepatocyte-like cells (HLCs).
Main Results:
- Small-molecule cocktail CIP (CHIR99021, IDE1, PD0332991) efficiently induced DE formation.
- The VDF cocktail successfully substituted growth factors for hepatic specification.
- Small-molecule-derived HLCs exhibited mature hepatocyte functions in vitro and liver repopulation capacity in vivo.
Conclusions:
- A stepwise, small-molecule-only protocol was established for efficient production of scalable HBs and mature HLCs.
- This method offers an efficient and cost-effective platform for large-scale production of functional human hepatic cells.
- The generated HLCs are suitable for cell-based therapy and drug discovery applications.
